Esperion Therapeutics, Inc. ($ESPR)
Halladay Benjamin โ Chief Financial Officer
Shares
213,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Halladay Benjamin |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Jul 13, 2026 |
| Expiration Date | Mar 14, 2035 |
| Transaction Code | D Sale to Issuer |
| Acquired/Disposed | Disposed |
| Security | Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Jul 13, 2026 |
| Shares Purchased | 213,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Derivative | Derivative |
| Accession Number | 0001628280-26-048000 |
| Document | View SEC Filing |